LKFT
Lakefront Biotherapeutics
$28.13
+$0.29 (+1.04%)Jul 27, 2026
Key metrics
The numbers that frame LKFT today
- Market cap
- $1.85B
- P/E (TTM)
- 3.2
- EV / FCF
- -4.1
- Gross margin
- 97.9%
- EV / Sales
- 1.5
- ROIC
- 15%
- Div yield
- 0%
- Debt / equity
- 0.0
- 52wk Low
- $26.42
- 52wk High
- $37.78
Growth
Revenue and earnings trend for LKFT
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about LKFT
Is Lakefront Biotherapeutics a good buy?
Hold. Lakefront Biotherapeutics has excellent quality, but weak momentum makes the setup mixed. Growth looks weak. That could put pressure on the long-term business case. We think Lakefront Biotherapeutics is selling at a fair price.
What is the market capitalization of LKFT?
Lakefront Biotherapeutics's market capitalization is $1.85B.
What is the P/E ratio for LKFT stock?
Lakefront Biotherapeutics's current P/E ratio is 3.2.
What is the 52-week high for LKFT stock?
The 52-week high for Lakefront Biotherapeutics is $37.78. The current close of $28.13 is 25.5% below that high.
What is the 52-week low for LKFT stock?
The 52-week low for Lakefront Biotherapeutics is $26.42. The current close of $28.13 is 6.5% above that low.
Does LKFT stock pay dividends?
Lakefront Biotherapeutics does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for LKFT?
Lakefront Biotherapeutics's Debt / Equity ratio is 0.